Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

Your doctor may prescribe one or more of the following treatments for platinum-resistant endometrial cancer. Chemotherapy involves the use of drugs to kill cancer cells. It may involve treatment ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

Endometrial cancer (EC) ranks as the second most prevalent gynecologic malignancy globally, with approximately 189,000 new ...

Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just ...

2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal ...

There are roughly 7,700 new cases of endometrial cancer each year in ... Zejula – as well as a phase 2 trial in non-small cell lung cancer (NSCLC). The company has predicted that Jemperli ...

Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.